责任编辑：钟离 格隆汇12月12日丨天孚通信(300394.SZ)公布，为持续推进公司国际化战略和全球化布局，打造国际化 资本运作平台，更好满足全球客户需求，助力公司高质量发展，公司拟在境外发行股份（H股）并在香 港联合交易所有限公司（简称"香港联交所"）上市，公司董事会授权公司管理层启动本次H股上市的前 期筹备工作。公司计划与相关中介机构就本次H股上市的具体推进工作进行商讨，关于本次H股上市的 细节尚未确定。 财经频道更多独家策划、专家专栏，免费查阅>> ...

本文源自：财华网 【财华社讯】12月5日，易点天下(301171.SZ)公告，为持续推进公司国际化战略和全球化布局，增强公 司的境外融资能力，进一步提升公司治理水平和核心竞争力，助力公司高质量发展，公司董事会授权管 理层启动H股上市的前期筹备工作，授权期限为自董事会审议通过之日起12个月内。 ...

智通财经APP讯，易点天下(301171.SZ)发布公告，为持续推进公司国际化战略和全球化布局，增强公司 的境外融资能力，进一步提升公司治理水平和核心竞争力，助力公司高质量发展，根据公司总体发展战 略及运营需要，公司拟在境外发行股份(H股)并在香港联合交易所有限公司上市，公司董事会授权公司 管理层启动本次H股上市的前期筹备工作，授权期限为自董事会审议通过之日起12个月内。 ...

易点天下（301171）(301171.SZ)发布公告，为持续推进公司国际化战略和全球化布局，增强公司的境 外融资能力，进一步提升公司治理水平和核心竞争力，助力公司高质量发展，根据公司总体发展战略及 运营需要，公司拟在境外发行股份(H股)并在香港联合交易所有限公司上市，公司董事会授权公司管理 层启动本次H股上市的前期筹备工作，授权期限为自董事会审议通过之日起12个月内。 ...

Core Viewpoint - The company emphasizes internationalization as a key strategy, aiming to enhance its presence in overseas markets where its market share is currently low [1] Group 1: International Expansion Strategy - The company is accelerating its overseas market layout by establishing subsidiaries in Hong Kong and Switzerland to support product development and commercialization [1] - The company has obtained product registration certificates in multiple countries and regions, facilitating its international market entry [1] Group 2: Sales and Management - The company is forming its own international sales team and strengthening the management and assessment of its agents to enhance market sales [1]

格隆汇11月24日丨宁波韵升(600366.SH)公布，公司于2025年11月24日召开第十一届董事会第十三次会 议，审议通过了《关于授权公司管理层启动公司境外发行股份(H股)并在香港联合交易所有限公司上市 相关筹备工作的议案》。为推进公司国际化战略、提升品牌形象及构建多元化资本平台，根据公司总体 发展战略及运营需要，公司拟在境外发行股份(H股)并在香港联合交易所有限公司(以下简称"香港联交 所")主板挂牌上市(以下简称"本次H股上市")，公司董事会授权公司管理层启动本次H股上市的前期筹备 工作。公司计划与相关中介机构就本次H股上市的具体推进工作进行商讨，关于本次H股上市的具体细 节尚未确定。 ...

宁波韵升（600366）(600366.SH)发布公告，为推进公司国际化战略、提升品牌形象及构建多元化资本 平台，根据公司总体发展战略及运营需要，公司拟在境外发行股份(H股)并在香港联合交易所有限公司 (简称"香港联交所")主板挂牌上市，公司董事会授权公司管理层启动本次H股上市的前期筹备工作。公 司计划与相关中介机构就本次H股上市的具体推进工作进行商讨，关于本次H股上市的具体细节尚未确 定。 ...

Core Viewpoint - Marubi Biotechnology announced plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance capital strength and international competitiveness [1][3] Group 1: Company Strategy - The company aims to accelerate its internationalization strategy and will consider the interests of existing shareholders during the issuance process [1] - The specific timing and details of the issuance will be determined by the board based on market conditions and regulatory approvals [1] Group 2: Financial Performance - For the first three quarters of 2025, Marubi achieved revenue of approximately 2.45 billion yuan, a year-on-year increase of 25.51%, and a net profit of about 244 million yuan, up 2.13% year-on-year [4] - The average selling prices of eye care, skin care, cleansing, and beauty products increased by 54.77%, 4.62%, 12.64%, and 24.78% respectively [4] Group 3: Operational Metrics - The accounts receivable turnover days decreased to 3.6 days from 6.32 days year-on-year, indicating improved efficiency in receivables management [5] - Inventory turnover days increased to 110.03 days from 98.94 days year-on-year, attributed to preemptive stocking for the "Double 11" shopping festival and increased safety stock due to business growth [5]

Group 1: H-share Listing Announcement - The company has authorized its management to initiate the preparation for issuing H-shares and listing on the Hong Kong Stock Exchange [1] - The decision was made during the 25th meeting of the 5th Board of Directors held on November 10, 2025, to enhance internationalization and global layout [1] - The authorization is valid for 12 months from the date of the board's approval, and the listing is subject to various regulatory approvals [1] Group 2: Shareholding and Reduction Plan - The controlling shareholder, Shandong Zhongji Investment Holding Co., plans to reduce its stake by up to 5.5 million shares, representing 0.49% of the total share capital [2] - The reduction will occur through block trading within a three-month period starting from October 28, 2025, to January 27, 2026, with a maximum of 1% of total shares in any 90-day period [2] - The estimated cash proceeds from the reduction, based on the last closing price of 413.70 yuan, would be approximately 227.54 million yuan [2] Group 3: Current Shareholding Status - As of the announcement date, the controlling shareholder holds 126,940,135 shares, accounting for 11.42% of the total share capital [3] - The reduction plan will not lead to a change in control or affect the company's governance structure and ongoing operations [4] - The actual controller of the company is Wang Weixiu, who is also the chairman of Zhongji Holding [4]

Core Viewpoint - The company, Proya (603605.SH), has announced its plan to issue H-shares and apply for listing on the Hong Kong Stock Exchange to accelerate its international strategy and enhance overseas business development [1] Group 1 - The board of directors has approved the proposal for issuing H-shares [1] - The move aims to strengthen the company's overseas financing capabilities [1] - The initiative is part of the company's overall development strategy and operational needs [1]